Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study (Q56979113)

From Wikidata

Jump to navigation Jump to search

scientific article published on 02 December 2012

Language	Label	Description	Also known as
English	Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study	scientific article published on 02 December 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Alessandro Granito

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Fabio Piscaglia

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

M Galassi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

L Romanini

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

V Lucidi

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

M Renzulli

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

A Borghi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

L Grazioli

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

R Golfieri

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

L Bolondi

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

language of work or name

0 references

publication date

2 December 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

37

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

355-363

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Multistep human hepatocarcinogenesis: correlation of imaging with pathology

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Liver biopsy in the diagnosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Imaging of hepatocellular carcinoma by computed tomography and magnetic resonance imaging: state of the art.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

The radiological diagnosis of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Potential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12166

21 January 2018

Identifiers

10.1111/APT.12166

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199022%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56979113&oldid=1750604779"